Reports cytotoxic effects of new triterpenoids in HepG2 cells, suggesting potential for cancer treatment.
Ganoderma leucocontextum, a valuable medicinal mushroom from Tibet, is rich in bioactive metabolites. In this study, three new lanostane-type triterpenoids (ganoleucocontins S–U, 1–3) were isolated from its ethanol extract via repeated column chromatography and HPLC, and their structures, including planar skeletons and stereochemical configurations, were determined through detailed spectroscopic analyses using HRTOFMS and NMR. All compounds feature a classic lanostane scaffold with high oxygenation. Cytotoxicity assays showed they exerted moderate inhibitory effects on the HepG2 cell line, with IC50 values of 22.15 ± 2.62, 35.24 ± 4.45, and 19.86 ± 4.33 μM, respectively. These findings enrich the structural diversity of Ganoderma triterpenoids and highlight their potential as anti-hepatocellular carcinoma leads.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: